Price: $111.59, Change: $+0.58, Percent Change: +0.53%
Related Articles
Research
Research Alert: CFRA Reiterates Sell Opinion On Shares Of The Bank Of Nova Scotia
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target price by CAD5 to CAD79, 8.7x our FY 27 (Oct.) EPS view, a discount to the peer average of 14.7x given inconsistent execution. We raise our FY 26 EPS view to CAD8.41 from CAD8.21 and increase FY 27's to CAD9.12 from CAD9.06. Our revenue projections are CAD39.8 billion for 2026 and CAD41.7 billion for 2027. Despite optimistic comments from management regarding balance sheet growth, we continue to be disappointed. In the Apr-Q, loans were flat year-over-year, and we don't believe the recent uptick in commercial balances will be sufficient to bring BNS's growth rate in line with its peers. Deposits are equally concerning, declining 1% year-over-year. Furthermore, despite management's confidence in earnings growth, the bank raised its quarterly dividend by only 3.6% to CAD1.14, a modest increase. On a positive note, BNS has improved its efficiency metrics alongside other Canadian banks, with meaningful gains in both ROE and productivity ratio in recent quarters.
$BNS
Research
Research Alert: CFRA Reiterates Sell Opinion On Shares Of The Bank Of Nova Scotia
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month target price by USD3 to USD57, 8.7x our FY 27 (Oct.) EPS view of CAD9.12 (USD6.60), a discount to the peer average of 14.7x given inconsistent execution. We raise our FY 26 EPS view to CAD8.41 from CAD8.21 and increase FY 27's to CAD9.12 from CAD9.06. Our revenue projections are CAD39.8 billion for 2026 and CAD41.7 billion for 2027. Despite optimistic comments from management regarding balance sheet growth, we continue to be disappointed. In the Apr-Q, loans were flat year-over-year, and we don't believe the recent uptick in commercial balances will be sufficient to bring BNS's growth rate in line with its peers. Deposits are equally concerning, declining 1% year-over-year. Furthermore, despite management's confidence in its earnings growth, the bank raised its quarterly dividend by only 3.6% to CAD1.14, a modest increase. On a positive note, BNS has improved its efficiency metrics alongside other Canadian banks, with meaningful gains in both ROE and productivity ratio in recent quarters.
$BNS
Research
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Deckers Outdoor
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of $169, based on 22.5x our FY 27 EPS estimate of $7.50 and slightly lower than the company's three-year average forward P/E multiple of 23.2x, reflecting decelerating growth but above peer margins and top-line growth. We maintain our FY 27 EPS estimate of $7.50 and initiate our FY 28 EPS estimate at $8.15. DECK posted solid FQ4 results with FY 27 guidance mostly in line with consensus estimates. The company expects full-year sales growth above 7.5% and EPS in the range of $7.30 to $7.45. The company sees some margin compression with operating margin of 21.5% after 23.1% in FY 26. Management also gave multi-year guidance. DECK sees revenue growth in the high single digits for 2028 through 2030 with operating margin in the low twenties (essentially flat), but it expects EPS growth in the low double digits annually on revenue growth and share repurchases. DECK remains a top pick in footwear thanks to its relative valuation (16x NTM EPS estimates) and strong fundamentals.
$DECK